Hilotherapy-study on Prevention of Oxaliplatin-induced Peripheral Neuropathy
NCT04913376
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Quality of Life
Chemotherapy-induced Peripheral Neuropathy
Interventions
DEVICE:
Hilotherapy
Sponsor
Universitaire Ziekenhuizen KU Leuven